Docon Technologies Sells 10% Stake in Thyrocare for ₹667.69 Crore

Thyrocare Technologies Limited announced that its promoter, Docon Technologies Private Limited, sold 53,32,860 equity shares of the company through open market transactions. The sale represents approximately 10% of the total paid-up equity capital of Thyrocare and fetched an aggregate gross consideration of ₹667.69 crore, at an average price of ₹1,252.03 per share. 

Docon Technologies Reduces Stake in Thyrocare

Following the transaction, Docon Technologies continues to remain a promoter of Thyrocare Technologies Limited. However, its shareholding has decreased from 70.98% to 60.93%. The transaction, executed through market trades, reflects a strategic adjustment in promoter holdings without impacting overall control of the company. The settlement of the transaction will be completed as per applicable legal and regulatory provisions.

Transaction Details and Market Implications

The sale involved 53,32,860 shares, executed on October 24, 2025, generating ₹667.69 crore in total proceeds. The average selling price of ₹1,252.03 per share indicates stable investor demand for Thyrocare’s stock despite the large promoter offload. Such transactions often attract institutional interest, reflecting confidence in the company’s long-term fundamentals. 

Importantly, Docon Technologies retains a significant majority holding post-sale, ensuring continuity in ownership and management alignment.

Read More: PNB Divests 10% Stake in Canara HSBC Life Insurance via IPO Offer for Sale!

Regulatory Disclosure and Compliance

The official communication was filed by Thyrocare Technologies Limited with both BSE and NSE. Signed by Brijesh Kumar, Company Secretary and Compliance Officer, the disclosure ensures transparency under SEBI’s corporate governance framework. The company reaffirmed that Docon Technologies remains part of the promoter group, maintaining effective control over the business despite the partial stake sale.

Thyrocare Technologies Share Price Performance

On October 24, 2025, Thyrocare Technologies share price opened at ₹1,262.00 on NSE, above the previous close of ₹1,244.90. During the day, it surged to ₹1,279.00 and dipped to ₹1,252.00. The stock is trading at ₹1,271.10 as of 12:03 PM. The stock registered a significant gain of 2.10%.

Over the past week, it has moved up by 2.76%, over the past month, it has moved up by 5.96%, and over the past 3 months, it has declined by 2.87%.

Conclusion

Docon Technologies’ sale of a 10% stake in Thyrocare Technologies for ₹667.69 crore marks a notable capital market transaction in the diagnostics sector. With promoter shareholding now at 60.93%, the company maintains promoter stability while potentially broadening its institutional investor base. The transaction reinforces Thyrocare’s visibility among investors and highlights continued compliance with SEBI disclosure standards.

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities are subject to market risks. Read all related documents carefully before investing.